The National Institute for Health and Clinical Excellence has recently published guidance on the early management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Sotiris Antoniou, a member of the guideline development group, explains the implications for practice.
Prescriber’s Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case, a patient with Crohn’s disease has recently been diagnosed with uric acid renal stones. By Andrew Husband and Jessica Clemerson.
Pharmacist prescribing has been a reality since 2003. This article, based on the results of a detailed study carried out in the north east of England, evaluates the extent of pharmacist prescribing and identifies some of the barriers to maintaining and developing such services. By Wasim Baqir, Jessica Clemerson and Jim Smith.
Not all pharmacists who train as prescribers go on to make the most of their skills. In this commentary, Wasim Baqir and Jim Smith discuss the findings of a recent study of pharmacist prescribing in the north east of England.
Building trust between the pharmaceutical industry and the NHS must be ‘a two-way street’, according to speakers at this year’s annual ABPI conference. Hannah Pike reports.
Opioid-induced hyperalgesia (OIH) is often mistaken for other conditions. This case study highlights the difficult issues in the management of OIH and discusses the molecular mechanisms involved in opioid sensitisation. By Tania Jones.
Paula Crawford is lead clinical pharmacist at Musgrave Park Hospital in Belfast, specialising in acute and chronic pain. In this article, she draws on her own experience to describe how pharmacists can play an integral part in the development of NICE clinical guidelines.
For pharmacy to secure a place amongst the clinical professions, we must hand the dispensing baton to robots and focus on medicines safety, says Philip Brown.